Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated May 21, 2024 to the Stock exchanges regarding Earning call in respect of the audited (Standalone and Consolidated) Financial Results of the company for the fourth Quarter and year ended March 31, 2024, we wish to inform that the said Earning Call was held today at 04:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q4FY24-earning-call-audio.mp3 Kindly take the above on records.

pdf

Concord Biotech Ltd.

27 May 2024, 06:21PM

1635.70

6.44%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to regulation 30 of schedule III Part A (LODR) regulation 2015, Investor Presentation on financial results for the fourth quarter and year ended March 31, 2024 is enclosed. Kindly take the above on records.

pdf

Concord Biotech Ltd.

16 Feb 2024

1635.70

6.44%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

In Continuation of our letter dated February 09, 2024 regarding audio recording of the unaudited (Standalone and Consolidated) financial results of the company for the Third Quarter and Nine months ended December 31, 2023 , transcripts of the earnings call for the said period enclosed herewith and available on the website of the company at the following link after sending this letter to you, https://www.concordbiotech.com/investors

pdf

Concord Biotech Ltd.

09 Feb 2024

1635.70

6.44%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated January 31, 2024 to the Stock exchanges regarding Earning call in respect of the Unaudited (Standalone and Consolidated) Financial Results of the company for the Third Quarter and Nine Months ended December 31, 2023, we wish to inform that the said Earning Call was held today at 02:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/q3fy24-earnings-audio-20240209175243.mp3 Kindly take the above on records.

pdf

Concord Biotech Ltd.

09 Feb 2024

1635.70

6.44%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of Schedule III Part A of SEBI (LODR) Regulations, 2015, "investors presentation" on the financial results for the Third Quarter and Nine months ended December 31, 2023 is enclosed.

pdf

Concord Biotech Ltd.

16 Nov 2023

1635.70

6.44%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

In Continuation of our letter dated November 09, 2023 regarding audio recording of the Unaudited (Standalone and consolidated) Financial results of the company for the quarter and half year ended September 30, 2023, Earnings call for investors and analysts and pursuant to regulation 30(6) of SEBI LODR, the transcripts of the earning call for the said period enclosed herewith.

pdf

Concord Biotech Ltd.

09 Nov 2023

1635.70

6.44%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated October 31, 2023 to the Stock exchanges regarding Earning call in respect of the Unaudited (Standalone and Consolidated) Financial Results of the company for the Quarter and half year ended September 30, 2023, we wish to inform that the said Earning Call was held today at 03:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q2FY24-Earnings-call-audio.mp3 Kindly take the above on records

pdf

Concord Biotech Ltd.

08 Nov 2023

1635.70

6.44%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to regulation 30 of Schedule III Part A of SEBI (Listing Obligations and disclosure requirements) Regulations, 2015, investors presentation on financial results for the quarter and half year ended on September 30, 2023 is enclosed.

pdf

Concord Biotech Ltd.

13 Sep 2023

1635.70

6.44%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

In continuation of our letter dated September 07, 2023 regarding audio recording of Q1FY 24 earning call for investor and anaysts and pursuant to regulation 30(6) of SEBI LODR, Please find enclosed transcripts of Q1 FY 24 earning call for the Quarter ended on June 30, 2023

pdf

38.60% Fall from 52W High

High volume+gain today

Concord Biotech Ltd. Earnings/Conference Calls

Concord Biotech Ltd. earnings concalls and investor presentations